The newly incorporated American Board of Artificial Intelligence in Medicine (ABAIM) is soon to begin credentialing healthcare workers in AI, machine learning and deep learning.

If medical AI makes a goof and causes a patient harm, the provider using the technology may be liable for malpractice. Or will the AI vendor be on the hook?

Owkin, a New York City-based AI startup, announced it is now working with the University of Pittsburgh to design and validate advanced machine learning models. Once finalized, the new models are expected to have a significant impact in areas such as clinical research and the development of pharmaceuticals.

Researchers are finalizing a new AI-powered smartphone app for assessing a user’s risk of being infected with the new coronavirus.

A new partnership between care.ai and the Texas Hospital Association (THA) is focused on getting AI-powered autonomous monitoring technology implemented throughout the Lone Star State.

Countless studies have explored AI’s impact on healthcare providers and the patients they serve—but what about the financial side of things? Looking purely at the bottom line, is AI a wise investment?

Suki, a healthcare technology company based out of Redwood City, California, has announced the completion of a Series B funding round worth $20 million.

The Healthcare Information and Management Systems Society (HIMSS) has officially canceled its 2020 annual meeting in Orlando, Florida, due to continued concerns over the new coronavirus.

AI could provide radiologists with significant value as an advanced peer review tool, according to new findings published in Academic Radiology.

Despite international travel interruptions due to COVID-19, HIMSS20 is moving “full steam ahead as scheduled” for March 9 to 13 in Orlando.